Spero Therapeutics (SPRO) Earnings Date, Estimates & Call Transcripts $2.80 -0.05 (-1.75%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$2.81 +0.01 (+0.36%) As of 06/11/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Spero Therapeutics Earnings Summary Spero Therapeutics issued Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.25, which topped analysts' consensus estimates of -$0.55 by $0.30. Quarterly revenue was reported to be $5.87 million, below the consensus estimate of $11 million. With a trailing EPS of -$1.28 and a P/E Ratio of 40.01, Spero Therapeutics' earnings are expected to grow next year, from ($1.20) to ($0.79) per share. Upcoming Q2 Earnings DateAug. 4After Market ClosesEstimatedConsensus EPS (May. 13) -$0.55 Actual EPS (May. 13) -$0.25 Beat By $0.30 Actual Revenue (May. 13) $5.87MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)SPRO Upcoming EarningsSpero Therapeutics' next earnings date is estimated for Monday, August 4, 2025, based on past reporting schedules. Powered by Get Spero Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spero Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSPRO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SPRO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Spero Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.33-$0.33-$0.33Q2 20251-$0.32-$0.32-$0.32Q3 20251-$0.25-$0.25-$0.25Q4 20251-$0.01-$0.01-$0.01 Spero Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/4/2025(Estimated)--------5/13/2025Q1 2025-$0.55-$0.25+$0.30-$0.25$11.00M$5.87M3/27/2025Q4 2024-$0.35-$0.38 -$0.03-$0.38$12.40M$15.04M8/5/2024Q2 2024-$0.34-$0.33+$0.01-$0.33$9.80M$10.20M5/15/2024Q1 2024-$0.07-$0.24 -$0.17-$0.24$16.80M$9.27M3/13/2024Q4 2023-$0.18$0.96+$1.14$0.96$19.40M$73.52M11/13/2023Q3 2023-$0.15$0.02+$0.17$0.10$2.40M$25.47M8/10/2023Q2 2023-$0.29-$0.23+$0.06-$0.23$2.20M$2.72M Spero Therapeutics Earnings - Frequently Asked Questions When is Spero Therapeutics's earnings date? Spero Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 4th, 2025 based off last year's report dates. Learn more on SPRO's earnings history. Did Spero Therapeutics beat their earnings estimates last quarter? In the previous quarter, Spero Therapeutics (NASDAQ:SPRO) reported ($0.25) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.55) by $0.30. Learn more on analysts' earnings estimate vs. SPRO's actual earnings. How much revenue does Spero Therapeutics generate each year? Spero Therapeutics (NASDAQ:SPRO) has a recorded annual revenue of $28.30 million. How much profit does Spero Therapeutics generate each year? Spero Therapeutics (NASDAQ:SPRO) has a recorded net income of $22.81 million. SPRO has generated -$1.28 earnings per share over the last four quarters. What is Spero Therapeutics's price-to-earnings ratio? Spero Therapeutics (NASDAQ:SPRO) has a trailing price-to-earnings ratio of 40.01. What is Spero Therapeutics's EPS forecast for next year? Spero Therapeutics's earnings are expected to grow from ($1.20) per share to ($0.79) per share in the next year. More Earnings Resources from MarketBeat Related Companies Phathom Pharmaceuticals Earnings Date ChromaDex Earnings Date Stoke Therapeutics Earnings Date Upstream Bio Earnings Date Taysha Gene Therapies Earnings Date Bicycle Therapeutics Earnings Date Mind Medicine (MindMed) Earnings Date Dianthus Therapeutics Earnings Date Kura Oncology Earnings Date Maravai LifeSciences Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:SPRO) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPRO Stock Free SPRO Stock Alerts